請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/58898完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 張芳嘉 | |
| dc.contributor.author | CHUN-YING FANG | en |
| dc.contributor.author | 方淳瀅 | zh_TW |
| dc.date.accessioned | 2021-06-16T08:37:30Z | - |
| dc.date.available | 2018-11-05 | |
| dc.date.copyright | 2013-11-05 | |
| dc.date.issued | 2013 | |
| dc.date.submitted | 2013-10-17 | |
| dc.identifier.citation | 1. Altena E, Van Der Werf YD, Strijers RL, Van Someren EJ. (2008). Sleep loss affects vigilance: effects of chronic insomnia and sleep therapy. Journal of Sleep Research, 17(3):335-343.
2. American Psychiatric. (2000). Diagnostic and Statistical Manual of Mental Disorders (4th ed.). Washington, DC, USA. 3. Ancoli-Israel S. (2000). Insomnia in the elderly: a review for the primary care practitioner. Sleep, 23(1) supplement: S23-S30. 4. Basheer R, Strecker RE, Thakkar MM, McCarley RW. (2004). Adenosine and sleep-wake regulation. Progress in Neurobiology, 73(6): 379-396. 5. Benarroch EE. (2008). Adenosine and its receptors: multiple modulatory functions and potential therapeutic targets for neurologic disease. Neurology, 70(3): 231-236. 6. Bhuiyan MB, Fant ME, Dasgupta A. (2003). Study on mechanism of action of Chinese medicine Chan Su: dose-dependent biphasic production of nitric oxide in trophoblastic BeWo cells. Clinica Chimica Acta, 330(1-2):179-84. 7. Bocca ML, Le Doze F, Etard O, Pottier M, L'Hoste J, Denise P. (1999). Residual effect of zolpidem 10 mg and zopiclone 7.5 mg versus flunitrazepam 1 mg and placebo on driving performance and ocular saccades. Psychopharmacology Berlin, 143(4): 373-9. 8. Buysse DJ, Thompson W, Scott J, PL Franzena, Germaina A, Halla M, Moula DE, Nofxingera EA, Kupfera DJ. (2007). Daytime symptoms in primary insomnia: a prospective analysis using ecological momentary assessment. Sleep Medicine, 8(3):198-208. 9. Buysse DJ. (2008). Chronic Insomnia. Am J Psychiatry, 165 (6): 678-86. 10. Calabrese EJ, Baldwin LA. (2003). Chemotherapeutics and hormesis. Critical Reviews in Toxicology, 33(3-4):305-53. 11. Calabrese EJ, Stanek EJ 3rd, Nascarella MA, Hoffmann GR. (2008). Hormesis predicts low-dose responses better than threshold models. International Journal of Toxicology, 27(5):369-78. 12. Calabrese EJ, Staudenmayer JW, Stanek EJ, Hoffmann GR. (2006). Hormesis outperforms threshold model in National Cancer Institute antitumor drug screening database. Toxicological Science, 94(2):368-78. 13. Cano G, Mochizuki T, Saper C. (2008). Neural Circuitry of Stress-Induced Insomnia in Rats. The Journal of Neuroscience, 28(40): 10167-10184. 14. Carlson NR. (2013). Physiology of Behavior (11th ed.), Pearson, Boston, USA. 15. Carús-Cadavieco M, de Andrés I. (2012). Adenosine and homeostatic control of sleep. Revue Neurologique, 55(7):413-20. 16. Chagoya de Sánchez V, Munoz RH, Suarez J, Vidrio S, Yanez L, Munoz MD. (1993). Day-night variations of adenosine and its metabolizing enzymes in the brain cortex of the rat-possible physiological significance for the energetic homeostasis and the sleep-wake cycle. Brain Research, 612(1-2): 115-121. 17. Chamberlin NL, Arrigoni E, Chou TC, Scammell TE, Greene RW, Saper CB. (2003). Effects of adenosine on GABAergic synaptic inputs to identified ventrolateral preoptic neurons. Neuroscience, 119(4): 913-918. 18. Chang FC, Opp MR. (1998). Blockade of corticotropin-releasing hormone receptors reduces spontaneous waking in the rat. American Journal of Physiology, 275 (3 Pt 2): R793-R802, 1998. 19. Chen FP, Jong MS, Chen YC, Kung YY, Chen TJ, Chen FJ, Hwang SJ. (2011). Prescriptions of Chinese Herbal Medicines for Insomnia in Taiwan during 2002. Evidence-Based Complementary and Alternative Medicine, Article ID 236341, 9 pages. doi:10.1093/ecam/nep018 20. Dixon AK, Gubitz AK, Sirinathsinghji DJ, Richardson PJ, Freeman TC. (1996). Tissue distribution of adenosine receptor mRNAs in the rat. British Journal of Pharmacology, 118(6): 1461-1468. 21. Doghramji K. (2006). The epidemiology and diagnosis of insomnia. American Journal of Managed Care, 12(8) supplement: S214-S220. 22. Edinger JD, Means MK, Carney CE, et al. (2008). Psychomotor performance deficits and their relation to prior nights’ sleep among individuals with primary insomnia. Sleep, 31(5):599-607. 23. Epstein AM, Fitzsimons JT, Rolls BJ.(1970). Drinking induced by injection of angiotensin into the brain of the rat. Journal of Physiology, 210(2): 457-4. 24. Erman, MK. (2007). Insomnia: Comorbidities and Consequences. Primary Psychiatry, 14 (6): 31-35. 25. factors contributing to the differential diagnosis of primary insomnia and insomnia related to mental disorders. American Journal of Psychiatry, 154(10):1412-1416. 26. Foltenyi K, Greenspan RJ, Newport JW. (2007). Activation of EGFR and ERK by rhomboid signaling regulates the consolidation and maintenance of sleep in Drosophila. Nature Neuroscience, 10(9): 1160-1167. 27. Fredholm BB, Arslan G, Halldner L., Kull B, Schulte G, Wasserman W. (2000). Structure and function of adenosine receptors and their genes. Naunyn-Schmiedeberg's Archives of Pharmacology, 362(4-5): 364-374. 28. Fredholm BB, Bättig K, Holmén J, Nehlig A, Zvartau EE. (1999) Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacological Reviews, 51(1):83-133. 29. Fredholm BB, Irenius E, Kull B, Schulte G. (2001). Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells. Biochemical Pharmacology, 61(4): 443-448. 30. Gallopin T, Luppi PH, Cauli B, Urade Y, Rossier J, Hayaishi O, Lambolez B, Fort P. (2005). The endogenous somnogen adenosine excites a subset of sleep-promoting neurons via A2A receptors in the ventrolateral preoptic nucleus. Neuroscience, 134(4):1377-90. 31. Gordi T, Frohna P, Sun HL, Wolff A, Belardinelli L, Lieu H. (2006). A population pharmacokinetic/pharmacodynamic analysis of regadenoson, an adenosine A2A receptor agonist, in healthy male volunteers. Clininal Pharmacokinetics, 45(12):1201-1212. 32. Haimov I, Hanuka E, Horowitz Y. (2008). Chronic insomnia and cognitive functioning among older adults. Behavioral Sleep Medicine, 6(1):32-54. 33. Harrison NL. (2007). Mechanisms of sleep induction by GABA(A) receptor agonists. Journal of Clinical Psychiatry, 68 supplement 5:S6-S12. 34. He ZX, Cwajg E, Hwang W, Hartley CJ, Funk E, Michael L, Verani M. (2000). Myocardial blood flow and myocardial uptake of (201)Tl and (99m)Tc-sestamibi during coronary vasodilation induced by CGS-21680, a selective adenosine A2A receptor agonist. Circulation, 102(4): 438-444. 35. Hoque R, Chesson AL Jr. (2009). Zolpidem-induced sleepwalking, sleep related eating disorder, and sleep-driving: fluorine-18- flourodeoxyglucose positron emission tomography analysis, and a literature review of other unexpected clinical effects of zolpidem. Journal of Clinical Sleep Medicine, 5(5): 471-476. 36. Huang NK, Chern Y, Fang JM, Lin CI, Chen WP. (2007). Neuroprotective principles from Gastrodia elata. Journal of Natural Products, 70(4):571-574. 37. Huang NK, Lin JH, Lin JT, Lin CI, Liu EM, Chern Y. (2011). A New Drug Design Targeting the Adenosinergic System for Huntington's Disease. PLoS ONE 6(6): e20934. doi:10.1371/journal.pone.0020934 38. Huang NK, Lin YL, Cheng JJ, Lai WL. (2004). Gastrodia elata prevents rat pheochromocytoma cells from serum-deprived apoptosis: the role of the MAPK family. Life Science, 75(13): 1649-1657. 39. Huang ZL, Qu WM, Equchi N, Chen JF, Schwarschild MA, Fredholm BB. (2005). Adenosine A2(A) , but not A1, receptors mediate the arousal effect of caffeine. Nature Neuroscience, 8(7):858-9. 40. Hus HY, Chen YP, Hsu SJ, Hsu CS, Chen CC, Chang HC.(1986). Oriental Materia Medica: a concise guide. Oriental Health Art Institute, California, USA:662. 41. Koenigs M, Holliday J, Solomon J, Grafman J. (2010). Left dorsomedial frontal brain damage is associated with insomnia. The Journal of Neuroscience, 30(47):16041-16043. 42. Koray B, Sesia T, Groenewegen H, Steinbusch H, Veerle Visser-Vandewalle, Yasin Temel. (2010). Nucleus Accumbens and Impulsivity. Progress in Neurobiology, 92(4):533-57. 43. Kryger M, Roth T, & Dement W. (2011). Principles and Practice of Sleep Medicine (5th ed.). St. Louis, Missouri, USA. 44. Kumar S, Rai S, Hsieh KC, McGinty D, Alam MN, Szymusiak R. (2013). Adenosine A2A receptors regulate the activity of sleep regulatory GABAergic neurons in the preoptic hypothalamus. Am J Physiol Regul Integr Comp Physiol, 305(1):R31-41. 45. Lazarus M, Shen HY, Cherasse Y, Qu WM, Huang ZL, Bass CE. (2011). Arousal effect of caffeine depends on adenosine A2(A) receptors in the shell of the nucleus accumbens. Journal of Neuroscience, 31(27):10067-75. 46. Meolie AL, Rosen C, Kristo D. (2005). “Oral nonprescription treatment for insomnia: an evaluation of products with limited evidence,” Journal of Clinical Sleep Medicine, 1(2):173-187. 47. Mingote S, Pereira M, Farrar AM, McLaughlin PJ, Salamone JD. (2008). Systemic administration of the adenosine A2A agonist CGS 21680 induces sedation at doses that suppress lever pressing and food intake. Pharmacology, Biochemistry and Behavior, 89(3): 345-351. 48. Murillo-Rodriguez E, Blanco-Centurion C, Gerashchenko D, Salin-Pascual RJ, Shiromani PJ. (2004). The diurnal rhythm of forebrain of young and adenosine levels in the basal old rats. Neuroscience, 123(2): 361-370. 49. Muzur A, Pace-Schott EF, Hobson JA. (2002). The prefrontal cortex in sleep. Trends in Cognitive Science, 6(11):475-481. 50. National Institutes of Health State. (2005). National Institutes of Health State of the Science Conference Statement on Manifestations and Management of Chronic Insomnia in Adults. NIH Consensuses and State-of-the- Science Statements, 22(2):1-30. 51. National Sleep Foundation. (2013). Insomnia and sleep, from http://www.sleepfoundation.org/article/sleep-related-problems/insomnia-and-sleep 52. Nowell PD, Buysse DJ, Reynolds CF, Hauri PJ, Kupfer DJ. (1997). Clinical 53. O'Donnell P, Goto Y. (2001). Synchronous activity in the hippocampus and nucleus accumbens in vivo. Journal of Neuroscience, 21(4):RC131. 54. Opp MR. (1998). Cytokines and sleep promotion: a potential mechanism for disorders of excessive daytime sleepiness. Pathogenesis, Diagnosis and Treatment of Sleep Apnea (Pack A, ed.). New York, USA. 55. Pawlyk AC, Morrison AR, Ross RJ, Brennan FX. (2008). Stress-induced changes in sleep in rodents: models and mechanisms. Neurosciene and Biobehavior Review, 32(1):99-117. 56. Paxinos G, Watson C. (1998). The Rat Brain in Stereotaxic Coordinates (4th ed.). Academic Press, San Diego, USA. 57. Porkka-Heiskanen T, Strecker RE, Thakkar M, Bjorkum AA, Greene RW, McCarley RW. (1997) Adenosine: a mediator of the sleep-inducing effects of prolonged wakefulness. Science, 276(5316): 1265-1268. 58. Revel FG, Gottowik J, Gatti S, Wettstein JG, Moreau JL. (2009). Rodent models of insomnia: a review of experimental procedures that induce sleep disturbances. Neuroscience & Biobehavioral Reviews, 33(6): 874-899. 59. Reynolds AR. (2010). Potential Relevance of Bell-Shaped and U-Shaped Dose-Responses for the Therapeutic Targeting of Angiogenesis in Cancer. Dose Response, 8(3):253-284. 60. Riemann D, Voderholzer U (2002). Consequences of Chronic (Primary) Insomnia: Effects on Performance, Psychiatric and Medical Morbidity–An Overview. Somnologie, 6 (3): 101-108. 61. Rosin DL, Robeva A, Woodard RL, Guyenet PG, Linden J. (1998). Immunohistochemical localization of adenosine A2A receptors in the rat central nervous system. Journal of Comparative Neurology, 401(2):163-186. 62. Saper CB, Scammell TE, Lu J. (2005). Hypothalamic regulation of sleep and circadian rhythms. Nature, 437(7063):1257-63. 63. Satoh S, Matsumura H, Suzuki F, Hayaishi O. (1996). Promotion of sleep mediated by the A2a-adenosine receptor and possible involvement of this receptor in the sleep induced by prostaglandin D2 in rats. Proceedings of the National Academy of Sciences USA, 93(12):5980-4. 64. Scammell T, Gerashchenko D, Urade Y, Onoe H, Saper C, Hayaishi O. (1998). Activation of ventrolateral preoptic neurons by the somnogen prostaglandin D2. Proc National Academy of Science of USA, 95 (13): 7754-9. 65. Scammell TE, Gerashchenko DY, Mochizuki T, McCarthy MT, Estabrooke IV, Sears CA, Saper CB, Urade Y, Hayaishi O. (2001). An adenosine A2A agonist increases sleep and induces Fos in ventrolateral preoptic neurons. Neuroscience,107(4):653-63. 66. Schwienbacher I, Fendt M, Richardson R, Schnitzler HU. (2004). Temporary inactivation of the nucleus accumbens disrupts acquisition and expression of fear-potentiated startle in rats. Brain Research, 1027(1-2):87-93. 67. Stenberg D, Litonius E, Halldner L, Johansson B, Fredholm BB, Porkka-Heiskanen T. (2003). Sleep and its homeostatic regulation in mice lacking the adenosine A1 receptor. Journal of Sleep Research, 12(4): 283-290. 68. Stenberg D. (2007). Neuroanatomy and neurochemistry of sleep. Cellular and Molecular Life Sciences, 64(10): 1187-1204. 69. Strecker RE, Morairty S, Thakkar MM, Porkka-Heiskanen T, Basheer R, Dauphin LJ, Rainnie DG., Portas CM, Greene RW, McCarley RW. (2000). Adenosinergic modulation of basal forebrain and preoptic/anterior hypothalamic neuronal activity in the control of behavioral state. Behavioural Brain Research, 115(2): 183-204. 70. Sugiura1 H, Akahane1 M, Ohkusa Y, Okabe N, Sano T, Jojima N, Bando H, Imamura1 T. (2013). Prevalence of Insomnia Among Residents of Tokyo and Osaka After the Great East Japan Earthquake: A Prospective Study. Interactive Journal of Medical Research, 2(1): e2 71. Svenningsson P, Le Moine C, Fisone G, Fredholm BB. (1999a) Distribution, biochemistry and function of striatal adenosine A2A receptors. Progress in Neurobiology, 59(4):355-396. 72. Taiwan Society of Sleep. (2009). 國人睡眠趨勢大調查. Taiwan. 73. Thakkar MM, Delgiacco RA, Strecker RE, McCarley RW. (2003). Adenosinergic inhibition of basal forebrain wakefulness-active neurons: a simultaneous unitrecording and microdialysis study in freely behaving cats. Neuroscience, 122(4):1107-13. 74. Urade Y, Eguchi N, Qu WM, Sakata M, Huang ZL, Chen JF, Schwarzschild MA, Fink JS, Hayaishi O. (2003). Sleep regulation in adenosine A2A receptor-deficient mice. Neurology, 61(11 Suppl 6) supplement:S94-6. 75. Van Someren EJ. (2000). Circadian and sleep disturbances in the elderly. Experimental Gerontology, 35(9-10):1229-37. 76. Victorri-Vigneau C, Dailly E, Veyrac G, Jolliet P. (2007). Evidence of zolpidem abuse and dependence: results of the French Centre for Evaluation and Information on Pharmacodependence (CEIP) network survey. British Journal of Clinical Pharmacology, 64(2):198-209. 77. Wafford KA, Ebert B. (2008). Emerging anti-insomnia drugs: tackling sleeplessness and quality of wake time. Nature Reviews Drug Discovery, 7(6): 530-540. 78. Yaar R, Jones MR, Chen JF, Ravid K. (2005). Animal models for the study of adenosine receptor function. Journal of Cellular Physiology, 202(1): 9-20. 79. Yang PF, Chen YY, Chen DY, Hu JW, Chen JH, Yen CT. (2013). Comparison of fMRI BOLD Response Patterns by Electrical Stimulation of the Ventroposterior Complex and Medial Thalamus of the Rat. PLoS One, 8(6):e66821. 10.1371/journal.pone.0066821. Print 2013. 80. Yang SL, Lin J, Xu JT. (2000). Research progress of Gastrodia elata. Chinese Traditional and Herbal Drugs, 31: 66-9. 81. Zhang J, Yin D, Wu F, Zhang G, Jiang C, Li Z, Wang L,Wang K. (2013). Microinjection of Adenosine into the Hypothalamic Ventrolateral Preoptic Area Enhances Wakefulness via the A1 Receptor in Rats. Neurochemical Research, 38(8):1616-23. 82. Zhang Y, Li M, Kang RX, Shi JG, Liu GT, Zhang JJ. (2012).NHBA isolated from Gastrodia elata exerts sedative and hypnotic effects in sodium pentobarbital-treated mice. Pharmacology, Biochemistry and Behavior, 102(3):450-457. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/58898 | - |
| dc.description.abstract | 失眠是最普遍的睡眠疾患之一。中草藥天麻在中國傳統醫學被用於抑制痙攣和失眠的治療。本研究探討天麻萃取物 T1-11在正常大鼠及失眠大鼠中，是否能發揮促進睡眠的作用，並進一步評估腺嘌呤1型受器與腺嘌呤2A型受器，是否參與 T1-11 之促眠作用。本研究結果發現，在正常大鼠施打 T1-11 會增加非速眼動睡眠，但對速眼動睡眠量則沒有顯著影響。T1-11 造成之非速眼動睡眠量增加，不會被選擇性腺嘌呤1型受器拮抗劑DPCPX阻斷，但會被選擇性腺嘌呤2A型受器拮抗劑 SCH 58261 阻斷，暗示腺嘌呤2A型受器在T1-11之促眠作用中所扮演的角色。T1-11亦會增加失眠大鼠之非速眼動睡眠，為T1-11將來應用於臨床失眠治療的可能性，提供支持性證據。 | zh_TW |
| dc.description.abstract | The rhizomes of Gastrodia elata, have traditionally been used in Chinese medicine for seizure suppression and the treatment of insomnia. This study was performed to investigate whether T1-11, an ethanol extract (an active ingrediant) of G. elata, produces somnogenic effects in normal and insomniac rats. We further evaluated the involvement of adenosine 2A receptors (A2AR) and adenosine 1 receptors (A1R) in the T1-11-mediated somnogenic effects. Administration of T1-11 increased non-rapid eye movement (NREM) sleep. The amount of rapid-eye movement (REM) sleep was not significantly changed. 8-Cyclopentyl-1,3-dipropylxanthine (DPCPX), a selective A1R antagonist, did not block the T1-11-induced enhancement of NREM sleep, whereas 5-amino-7-(β-phenylethyl)-2-(8-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine (SCH 58261), a selective A2AR antagonist, significantly blocked the T1-11-induced enhancement of NREM sleep, indicating the role of A2AR in the somnogenic effect of T1-11. T1-11 increased NREM in the insomniac rats, providing evidence for the potential use of T1-11 in the treatment insomnia in clinic. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-16T08:37:30Z (GMT). No. of bitstreams: 1 ntu-102-R99629037-1.pdf: 2520587 bytes, checksum: 9a39d0e67d21e21c8f879b822bb4d5d7 (MD5) Previous issue date: 2013 | en |
| dc.description.tableofcontents | TABLE OF CONTENTS
ABSTRACT 1 INTRODUCTION 3 MATERIALS AND METHODS 11 2.1 Drugs 11 2.2 Animals and surgeries 12 2.3 Apparatus 13 2.4 Experimental protocols 15 2.4.1 To determine the effect on spontaneous sleep 15 2.4.2 Cage-exchange-induced insomnia 16 2.5 Statistical analysis 16 RESULTS 18 3.1 Effects of intracerebroventricular administration of CGS 21680 in rats 18 3.2 Effects of intracerebroventricular administration of T1-11 in rats 19 3.3 Role of adenosine receptors in the somnogenic effect of T1-11 in rats 21 3.3.1 Effect of the selective adenosine 1 receptor antagonist (DPCPX) on the T1-11-induced enhancement of NREM sleep 21 3.3.2 Effect of the selective adenosine 2A receptor antagonist (SCH 58261) on the T1-11-induced enhancement of NREM sleep 23 3.4 Insomniac rats: cage exchange model 24 3.5 The somnogenic effect of T1-11 in insomniac rats 25 DISCUSSION 27 4.1 The somnogenic effect of T1-11 in normal rats 27 4.1.1 T1-11 enhanced NREM sleep in a two-phase manner 29 4.1.2 T1-11 exhibited a bell-shape dose-dependent curve 30 4.1.3 SCH 58261, but not DPCPX, blocked the T1-11 – induced NREM sleep enhancement 33 4.2 The somnogenic effects of T1-11 in insomniac rats 35 4.2.1 The cage-exchange insomnia model 35 4.2.2 The somnogenic effect of T1-11 in insomniac rats 38 FIGURES 43 TABLES 63 REFERENCES 69 | |
| dc.language.iso | en | |
| dc.subject | 天麻 | zh_TW |
| dc.subject | 失眠 | zh_TW |
| dc.subject | 大鼠 | zh_TW |
| dc.subject | T1-11 | zh_TW |
| dc.subject | 腺嘌呤受器 | zh_TW |
| dc.subject | adenosine receptors | en |
| dc.subject | T1-11 | en |
| dc.subject | insomnia | en |
| dc.subject | rat | en |
| dc.subject | Gastrodia elata | en |
| dc.title | 天麻萃取物 T1-11 於大鼠之促眠作用 | zh_TW |
| dc.title | The somnogenic effects of T1-11, derived from Gastrodia elata, in Rats | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 102-1 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 詹東榮,林雲蓮 | |
| dc.subject.keyword | T1-11,天麻,腺嘌呤受器,失眠,大鼠, | zh_TW |
| dc.subject.keyword | T1-11,Gastrodia elata,adenosine receptors,insomnia,rat, | en |
| dc.relation.page | 81 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2013-10-17 | |
| dc.contributor.author-college | 獸醫專業學院 | zh_TW |
| dc.contributor.author-dept | 獸醫學研究所 | zh_TW |
| 顯示於系所單位： | 獸醫學系 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-102-1.pdf 未授權公開取用 | 2.46 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。